Back to full list of clinical trials

Ongoing clinical trials for HIV and hepatitis C co-infection: Actively recruiting


Condition:

HCV/HIV co-infection

Study title:

A5294: A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects

Description of study:

This study will evaluate the safety, efficacy and tolerability of the drug boceprevir in combination with Peginterferon and Ribavirin for the treatment of HCV in co-infected patients

Basic eligibility criteria:

Adults coinfected with HCV genotype 1 and HIV

Principal Investigator:

Arthur Kim, MD

Contact:

Teri Flynn, RN, MSN, ANP; 617-726-5596


Ongoing clinical trials for HIV and hepatitis C co-infection: No longer recruiting


Study title:

Open Label Study of Safety and Efficacy with BMS-790052 plus PEG/RBV in Previously Untreated HCV Patients Co-infected with HIV and HCV

Description of study:

This study will evaluate the safety, efficacy and tolerability of the drug BMS-790052 in combination with Peginterferon and Ribavirin for the treatment of HCV in co-infected patients.

Principal Investigator:

Arthur Kim, MD

Back to Top